WPD Pharmaceuticals (WPDPD) Stock Statistics & Valuation Metrics

WPD Pharmaceuticals has a market cap or net worth of $608.44K. The enterprise value is ―.

WPD Pharmaceuticals has 4,639,485 shares outstanding. The number of shares has decreased by -2.65% in one year.

WPD Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of WPD Pharmaceuticals is ―. WPD Pharmaceuticals’s PEG ratio is ―.

In the last 12 months, WPD Pharmaceuticals had revenue of 0.00 and earned -80.08K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -171.99K and capital expenditures 0.00, giving a free cash flow of -171.99K billion.

WPD Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

WPD Pharmaceuticals upcoming earnings date is May 28, 2025, TBA Not Confirmed.

WPD Pharmaceuticals as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, WPD Pharmaceuticals has paid 0.00 in taxes.

WPD Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

WPD Pharmaceuticals has $9.34K in cash and marketable securities with C$15.96K in debt, giving a net cash position of $381.54K billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for WPD Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―